Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2006 1
2007 2
2008 1
2009 1
2010 1
2012 1
2013 3
2014 2
2015 2
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kanamoto t (196 results)?
Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study.
Iwahashi M, Inoue H, Matsubara T, Tanaka T, Amano K, Kanamono T, Nakano T, Uchimura S, Izumihara T, Yamazaki A, Karyekar CS, Takeuchi T. Iwahashi M, et al. Among authors: kanamono t. Mod Rheumatol. 2014 Nov;24(6):885-91. doi: 10.3109/14397595.2014.881954. Epub 2014 Apr 7. Mod Rheumatol. 2014. PMID: 24708204 Clinical Trial.
Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies.
Hayashi M, Kobayakawa T, Takanashi T, Yamazaki H, Ishikawa H, Kanamono T. Hayashi M, et al. Among authors: kanamono t. Clin Rheumatol. 2013 Jul;32(7):961-7. doi: 10.1007/s10067-013-2210-x. Epub 2013 Feb 10. Clin Rheumatol. 2013. PMID: 23397148 Clinical Trial.
Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders.
Amano K, Matsubara T, Tanaka T, Inoue H, Iwahashi M, Kanamono T, Nakano T, Uchimura S, Izumihara T, Yamazaki A, Karyekar CS, Takeuchi T; Japan Abatacept Study Group. Amano K, et al. Among authors: kanamono t. Mod Rheumatol. 2015 Sep;25(5):665-71. doi: 10.3109/14397595.2015.1012786. Mod Rheumatol. 2015. PMID: 25698370
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
Hara M, Ishiguro N, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Yamamoto K; Iguratimod-Clinical Study Group. Hara M, et al. Mod Rheumatol. 2014 May;24(3):410-8. doi: 10.3109/14397595.2013.843756. Epub 2013 Nov 7. Mod Rheumatol. 2014. PMID: 24252050 Clinical Trial.
A Fatal Case of Relapsing Pneumonia Caused by Legionella pneumophila in a Patient with Rheumatoid Arthritis After Two Injections of Adalimumab.
Hayashi M, Kuraishi H, Masubuchi T, Furihata K, Aida Y, Kobayakawa T, Deguchi M, Kojima T, Ishiguro N, Kanamono T. Hayashi M, et al. Among authors: kanamono t. Clin Med Insights Case Rep. 2013 Jun 12;6:101-6. doi: 10.4137/CCRep.S11641. Print 2013. Clin Med Insights Case Rep. 2013. PMID: 23843716 Free PMC article.
16 results